Special considerations concerning the use of antiretroviral drugs in children.

about

Special considerations concerning the use of antiretroviral drugs in children.

Item

http://www.wikidata.org/entity/Q40535139

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Special considerations concerning the use of antiretroviral drugs in children.

@en

type

Item

label

Special considerations concerning the use of antiretroviral drugs in children.

@en

prefLabel

Special considerations concerning the use of antiretroviral drugs in children.

@en

P1476

Special considerations concerning the use of antiretroviral drugs in children.

@en

P2093

Josiane Warszawski

http://www.w3.org/2001/XMLSchema#string

Naïm Bouazza

http://www.w3.org/2001/XMLSchema#string

Patricia Fassinou

http://www.w3.org/2001/XMLSchema#string

Pierre Frange

http://www.w3.org/2001/XMLSchema#string

Stéphane Blanche

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era

Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses

Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy

Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells

Early antiretroviral therapy and mortality among HIV-infected infants

Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral blood.

Absence of detectable HIV-1 viremia after treatment cessation in an infant.

HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment

P304

1155-1163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14787210.2016.1236686

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27645375

http://www.w3.org/2001/XMLSchema#string